AD/PD 2026: Candidate Biomarkers of Oligodendrocyte Involvement in AD

Despite increasing evidence of oligodendrocyte involvement in the pathophysiology of Alzheimer’s disease, biomarkers linked to amyloid pathology remain insufficiently characterised. In this MEDtalk from the AD/PD 2026 Conference, Luiza Machado, Doctoral Student at the University of Gothenburg, Sweden, presents results from her poster addressing this question.